SEC 13F Intelligence

Boxer Capital, LLC / DAWNGBX

Boxer Capital, LLC’s Day One Biopharmaceuticals I Position

Does Boxer Capital, LLC own Day One Biopharmaceuticals I (DAWNGBX)? Not currently — the last reported position was 1.19M shares worth $17M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$17M
Q3 2024
Shares
1.19M
% of Portfolio
+0.81%
Quarters Held
14
position exited

Position History DAWNGBX

Reported value by quarter
Q2 ’21: $27MQ2 ’21Q3 ’21: $28MQ4 ’21: $20MQ4 ’21Q1 ’22: $12MQ2 ’22: $21MQ2 ’22Q3 ’22: $24MQ4 ’22: $26MQ4 ’22Q1 ’23: $15,910Q2 ’23: $14,208Q2 ’23Q3 ’23: $15MQ4 ’23: $17MQ4 ’23Q1 ’24: $20MQ2 ’24: $16MQ2 ’24Q3 ’24: $17Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.19M$17M+0.81%
Q2 20241.19M$16M+0.86%
Q1 20241.19M$20M+0.97%
Q4 20231.19M$17M+0.87%
Q3 20231.19M$15M+0.78%
Q2 20231.19M$14,208+0.66%
Q1 20231.19M$15,910+0.78%
Q4 20221.19M$26M+1.35%
Q3 20221.19M$24M+1.34%
Q2 20221.19M$21M+1.35%
Q1 20221.19M$12M+0.61%
Q4 20211.19M$20M+0.78%
Q3 20211.19M$28M+0.99%
Q2 20211.19M$27M+0.96%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of DAWNGBX.